KI-Beratung Beta

Produktbild: Cancer Gene Therapy by Viral and Non-Viral Vectors

Cancer Gene Therapy by Viral and Non-Viral Vectors

Aus der Reihe Translational Oncology

Fr. 223.00

inkl. gesetzl. MwSt., Versandkostenfrei


Beschreibung

Provides expert, state-of-the-art insight into the current progress of viral and non-viral gene therapy   Translational medicine has opened the gateway to the era of personalized or precision medicine. No longer a one-size-fits-all approach, the treatment of cancer is now based on an understanding of underlying...

Beschreibung

Provides expert, state-of-the-art insight into the current progress of viral and non-viral gene therapy
 
Translational medicine has opened the gateway to the era of personalized or precision medicine. No longer a one-size-fits-all approach, the treatment of cancer is now based on an understanding of underlying biologic mechanisms and is increasingly being tailored to the molecular specificity of a tumor.
This book provides a comprehensive overview of the pertinent molecular discoveries in the cancer field and explains how these are being used for gene-based cancer therapies. Designed as a volume in the Translational Oncology book series, Cancer Gene Therapy by Viral and Non-viral Vectors deals with the practice of gene-therapy, with reference to vectors for gene expression and gene transfer, as well as viral therapy. It covers the history and current and future applications of gene transfer in cancer, and provides expert insight on the progress of viral and non-viral gene therapy with regard to delivery system, vector design, potential therapeutic genes, and principles and regulations for cancer gene therapy.
Presented in three parts, Cancer Gene Therapy by Viral and Non-viral Vectors covers:
 
Delivery Systems
 
* Translational Cancer Research: Gene Therapy by Viral and Non-viral Vectors
 
* Retroviruses for Cancer Therapy
 
* DNA Plasmids for Non-viral Gene Therapy of Cancer
 
* Cancer Therapy with RNAi delivered by Non-viral Membrane/Core Nanoparticles
 
Targeted Expression
 
* Cancer Gene Therapy by Tissue-specific and Cancer-targeting Promptors
 
* MicroRNAs as Drugs and Drug Targets in Cancer
 
Principles of Clinical Trials in Gene Therapy
 
* Regulatory issues for Manufacturers of Viral Vectors and Vector-transduced Cells for Phase I/II Trials
 
* US Regulations Governing Clinical Trials in Gene Therapy
 
* Remaining Obstacles to the Success of Cancer Gene Therapy
 
Focusing on speeding the process in clinical cancer care by bringing therapies as quickly as possible from bench to bedside, Cancer Gene Therapy by Viral and Non-viral Vectors is an absolutely vital book for physicians, clinicians, researchers, and students involved in this area of medicine.

Produktdetails

Einband

Gebundene Ausgabe

Erscheinungsdatum

17.03.2014

Herausgeber Malcolm Brenner + weitere
Verlag John Wiley & Sons Inc

Produktdetails

Einband

Gebundene Ausgabe

Erscheinungsdatum

17.03.2014

Herausgeber
Verlag John Wiley & Sons Inc
Seitenzahl

176

Maße (L/B/H)

25.7/18.3/1.5 cm

Gewicht

590 g

Auflage

1. Auflage

Sprache

Englisch

ISBN

978-1-118-50162-7

Herstelleradresse

Libri GmbH
Europaallee 1
36244 Bad Hersfeld
DE

Email: gpsr@libri.de

Noch keine Bewertungen vorhanden

Verfassen Sie die erste Bewertung zu diesem Artikel

Helfen Sie anderen Kundinnen und Kunden durch Ihre Meinung.

Kundinnen und Kunden meinen

Bewertungen (0)

Die Leseprobe wird geladen.
  • Produktbild: Cancer Gene Therapy by Viral and Non-Viral Vectors
  • List of Contributors, vii
     
    Series Foreword, ix
     
    Preface, xi
     
    Part I Delivery Systems
     
    1 Translational Cancer Research: Gene Therapy by Viral and Non-viral Vectors, 3
    Vincenzo Cerullo, Kilian Guse, Markus Vähä-Koskela, and Akseli Hemminki
     
    2 Retroviruses for Cancer Therapy, 21
    Jiehua Zhou, Yue Ding, John C. Burnett, and John Rossi
     
    3 DNA Plasmids for Non-viral Gene Therapy of Cancer, 39
    Amer M. Najjar, Judy S.E. Moyes, and Laurence J.N. Cooper
     
    4 Cancer Therapy with RNAi Delivered by Non-viral Membrane/Core Nanoparticles, 61
    Andrew B. Satterlee and Leaf Huang
     
    Part II Targeted Expression
     
    5 Cancer Gene Therapy by Tissue-specific and Cancer-targeting Promoters, 81
    Jennifer L. Hsu, Longfei Huo, Chia-Wei Li, Yi-Hsin Hsu, Yan Wang, and Mien-Chie Hung
     
    6 MicroRNAs as Drugs and Drug Targets in Cancer, 97
    Hui Ling and George A. Calin
     
    Part III Principles of Clinical Trials in Gene Therapy
     
    7 Regulatory Issues for Manufacturers of Viral Vectors and Vector-transduced Cells for Phase I/II Trials, 115
    Adrian P. Gee and Zhuyong Mei
     
    8 US Regulations Governing Clinical Trials in Gene Therapy, 131
    Bambi Grilley
     
    9 Remaining Obstacles to the Success of Cancer Gene Therapy, 151
    Malcolm K. Brenner
     
    Index, 157